Stroke and cognitive disorders

Захаров, Владимир; Вахнина, Н. В.

doi:10.14412/2074-2711-2011-141

Cited by 14 publications

(6 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Уже в первые месяцы после инсульта у большинства больных выявляются КН. При этом распространенность недементных КН варьирует от 30 до 68%, а встречаемость самого тяжелого вида КН -постинсультной деменции находится в пределах 7-40% в зависимости от возраста пациента и тяжести перенесенного инсульта [21][22][23][24][25]. Наличие КН у пациента, перенесшего инсульт, отрицательно сказывается на продолжительности жизни.…”

Section: когнитивные нарушения и деменция: определение и классификацияunclassified

Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation

Остроумова

Кочетков

Korchagina

et al. 2019

Racionalʹnaâ farmakoterapiâ v kardiologii

View full text Add to dashboard Cite

Atrial fibrillation (AF) is one of the most common cardiac arrhythmias in clinical practice and important additional risk factor for the development of cognitive impairment (CI) and dementia as it has been shown in recent studies. According to the Diagnostic and statistical manual of mental disorders latest revision CI refers to a decrease of one or more higher cortical functions that provide the processes of perception, storage, transformation and transmission of information compared to the premorbid level. The main hypothesis that explains the relationship between AF and dementia is the assumption that in the presence of this arrhythmia a brain substance is damaged due to microembolism and cerebral microbleeding. The high clinical significance of AF as well as CI served as a background for the development by European experts several consensus documents concerning the problem of the relationships between these conditions. In addition, they emphasize the role of anticoagulant therapy as a preventing tool for the development of stroke, which can be a factor in the CI progression in patients with AF, with particular priority to direct oral anticoagulants (DOACs). In randomized clinical trials, meta-analyses and systematic reviews have been shown that the use of DOACs, as compared to vitamin K antagonists, is a more rational strategy for preventing stroke associated with AF. Among the DOAC class, rivaroxaban is worth noticing as a drug that has a favorable efficacy profile for primary and secondary stroke prevention. Rivaroxaban distinguishing characteristics are a once daily administration as well as a calendar package which is practically important for patients with CI.

show abstract

Section: когнитивные нарушения и деменция: определение и классификацияunclassified

Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation

Остроумова

Кочетков

Korchagina

et al. 2019

Racionalʹnaâ farmakoterapiâ v kardiologii

View full text Add to dashboard Cite

show abstract

“…The acute cerebrovascular accidents rank the third place after the myocardial infarction and cancer in the list of death causes and they are the key factor of the population's disability: only 20% of post-ischemic stroke patients manage to recover. [1][2][3][4] Along with motor and sensitivity defects most of the patients also suffer from cognitive defects that cause social maladjustment, complicate recovery processes, significantly reduce quality of life of both the patient and his family. [5][6][7][8][9][10][11][12] One of the most significant post-stroke cognitive defects is speech disorder.…”

Section: Introductionmentioning

confidence: 99%

Treatment of the post-stroke speech disorders in the patients with cardiac and cerebrovascular pathology

Koberskaya¹

2018

JNSK

View full text Add to dashboard Cite

“…Одним із найчастіших неврологічних симптомів при СД є порушення когнітивних функцій [7,8]. Оскільки вони пов'язані з інтегрованою діяльністю головного мозку у цілому, когнітивна недостатність закономірно розвивається при найрізноманітніших ураженнях головного мозку [9].…”

unclassified

Criteria for diagnosis of cognitive impairments in patients with hallucinatory-paranoid disorders in vascular dementia

Shevchenko-Bitensky¹

2019

MPS

View full text Add to dashboard Cite

Подано результати обстеження пацієнтів із судинною деменцією і галюцинаторно-параноїдними розладами та хворих без психотичних розладів. Установлено, що пацієнти з галюцинаторно-параноїдними розладами мали більш виражені когнітивні порушення (праксису, гнозису, пам'яті, навичок лічби, процесу уваги, мислення та орієнтації), ніж хворі без психотичних порушень.

show abstract

Stroke and cognitive disorders

Abstract: Cognitive disorders (CDs)

Cited by 14 publications

References 25 publications

Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation

Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation

Treatment of the post-stroke speech disorders in the patients with cardiac and cerebrovascular pathology

Criteria for diagnosis of cognitive impairments in patients with hallucinatory-paranoid disorders in vascular dementia

Contact Info

Product

Resources

About